These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 33024392)
21. Update on Emerging Pharmacologic Therapies for Patients With Eosinophilic Esophagitis. Syverson EP; Hait E Gastroenterol Hepatol (N Y); 2022 Apr; 18(4):207-212. PubMed ID: 35505944 [TBL] [Abstract][Full Text] [Related]
22. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis. Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220 [TBL] [Abstract][Full Text] [Related]
23. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis. Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of eosinophilic esophagitis - advancements and perspectives]. Miehlke S; Arnim UV; Schlag C; Labenz J; Madisch A Laryngorhinootologie; 2023 May; 102(5):339-348. PubMed ID: 37141876 [TBL] [Abstract][Full Text] [Related]
25. Steroids in pediatric eosinophilic esophagitis. Contreras EM; Gupta SK Gastroenterol Clin North Am; 2014 Jun; 43(2):345-56. PubMed ID: 24813520 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies. Lucendo AJ Expert Rev Clin Immunol; 2020 Jan; 16(1):63-77. PubMed ID: 31842634 [No Abstract] [Full Text] [Related]
27. Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice. Laserna-Mendieta EJ; Casabona S; Savarino E; Perelló A; Pérez-Martínez I; Guagnozzi D; Barrio J; Guardiola A; Asensio T; de la Riva S; Ruiz-Ponce M; Rodríguez-Oballe JA; Santander C; Arias Á; Lucendo AJ; Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2903-2911.e4. PubMed ID: 31988045 [TBL] [Abstract][Full Text] [Related]
28. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach. Munoz-Persy M; Lucendo AJ Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437 [TBL] [Abstract][Full Text] [Related]
32. Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme. Miehlke S; Schlag C; Lucendo AJ; Biedermann L; Vaquero CS; Schmoecker C; Hayat J; Hruz P; Ciriza de Los Rios C; Bredenoord AJ; Vieth M; Schoepfer A; Attwood S; Mueller R; Burrack S; Greinwald R; Straumann A; United European Gastroenterol J; 2022 Apr; 10(3):330-343. PubMed ID: 35412032 [TBL] [Abstract][Full Text] [Related]
33. Variability in Swallowed Topical Corticosteroid Practice Patterns for Treatment of Pediatric Eosinophilic Esophagitis. Syverson EP; Tobin M; Patton T; Franciosi JP; Gupta SK; Venkatesh RD J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):256-259. PubMed ID: 37204839 [TBL] [Abstract][Full Text] [Related]
34. Swallowed topical steroid therapy for eosinophilic oesophagitis in children: practical, evidence-based guidance by the BSPGHAN Eosinophilic Oesophagitis Working Group. Chan J; Flynn DM; Gordon M; Parmar R; Moolenschot K; Jackman L; Gaynor E; Epstein J; Cordell A; Kannappan H; Furman M; Thompson J; Gasparetto M; Auth MKH BMJ Paediatr Open; 2024 May; 8(1):. PubMed ID: 38782481 [TBL] [Abstract][Full Text] [Related]
35. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394 [TBL] [Abstract][Full Text] [Related]
36. Is There a Role for Topical Swallowed Steroids upon Emergency Room Admission for Suspected Food Bolus Obstruction in Eosinophilic Esophagitis? Schreiner P; Greuter T; Tatu A; Keller DI; Straumann A; Biedermann L Dysphagia; 2022 Aug; 37(4):933-936. PubMed ID: 34398319 [TBL] [Abstract][Full Text] [Related]
37. Maintenance Therapy With the Lowest Effective Dose of Oral Viscous Budesonide in Children With Eosinophilic Esophagitis. Oliva S; Volpe D; Russo G; Veraldi S; Papoff P; Giordano C; Ruggiero C; Trovato CM; Terrin G; Rossetti D Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2905-2907.e2. PubMed ID: 34555518 [TBL] [Abstract][Full Text] [Related]
38. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis. Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial. Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104 [TBL] [Abstract][Full Text] [Related]